Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
US Market
Holding CDT?
Track your performance easily

Conduit Pharmaceuticals (CDT) Technical Analysis

121 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Conduit Pharmaceuticals’s (CDT) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Conduit Pharmaceuticals is a Sell.
Conduit Pharmaceuticals’s (CDT) 20-Day exponential moving average is 0.15, while Conduit Pharmaceuticals’s (CDT) share price is $0.129, making it a Sell.
Conduit Pharmaceuticals’s (CDT) 50-Day exponential moving average is 0.40, while Conduit Pharmaceuticals’s (CDT) share price is $0.129, making it a Sell.

Conduit Pharmaceuticals (CDT) Pivot Points

Sep 20, 2024, 01:40 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.13
0.13
0.13
0.14
0.14
0.15
0.15
Fibonacci
0.13
0.13
0.13
0.14
0.14
0.14
0.15
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Conduit Pharmaceuticals (CDT) Moving Averages

Sep 20, 2024, 01:40 PM
Period
Simple
Exponential
MA5
0.13Sell
0.13Sell
MA10
0.13Sell
0.13Sell
MA20
0.14Sell
0.15Sell
MA50
0.18Sell
0.40Sell
MA100
1.23Sell
1.02Sell
MA200
2.41Sell
1.94Sell
Conduit Pharmaceuticals’s (CDT) 10-Day exponential moving average is 0.13, while Conduit Pharmaceuticals’s (CDT) share price is $0.129, making it a Sell.
Conduit Pharmaceuticals’s (CDT) 100-Day exponential moving average is 1.02, while Conduit Pharmaceuticals’s (CDT) share price is $0.129, making it a Sell.
Conduit Pharmaceuticals’s (CDT) stock price is $0.129 and Conduit Pharmaceuticals’s (CDT) 50-day simple moving average is 0.18, creating a Sell signal.
Conduit Pharmaceuticals’s (CDT) stock price is $0.129 and Conduit Pharmaceuticals’s (CDT) 100-day simple moving average is 1.23, creating a Sell signal.
Conduit Pharmaceuticals’s (CDT) stock price is $0.129 and Conduit Pharmaceuticals’s (CDT) 200-day simple moving average is 2.41, creating a Sell signal.

Conduit Pharmaceuticals (CDT) Technical Indicators

Sep 20, 2024, 01:40 PM
Name
Value
Implied Action
RSI (14)
30.38
Neutral
STOCH (9,6)
68.29
Neutral
STOCHRSI (14)
69.13
Neutral
MACD (12,26)
-0.04
Sell
ADX (14)
16.92
Buy
Williams %R
-43.75
Buy
CCI (14)
-35.92
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
52.06
Neutral
ROC
0.00
-
Conduit Pharmaceuticals’s (CDT) Relative Strength Index (RSI) is 30.38, creating a Neutral signal.
Conduit Pharmaceuticals’s (CDT) Trend Strength Indicator (ADX) is 16.92, creating a Buy signal.
Conduit Pharmaceuticals’s (CDT) Commodity Channel Index (CCI) is -35.92, creating a Neutral signal.

FAQ

Is CDT a Buy, Hold, or Sell?
Based on CDT’s technical indicators, CDT is a Strong Sell.
    What is CDT’s RSI (14)?
    CDT’s RSI (14) is 30.38, which suggests CDT is a Neutral.
      What is CDT’s MACD?
      CDT’s MACD is -0.04, which suggests CDT is a Sell.
        What is CDT’s 5-day moving average?
        CDT’s 5-day moving average is 0.13, which suggests CDT is a Sell.
          What is CDT’s 20-day moving average?
          CDT 20-day moving average is 0.14, which suggests CDT is a Sell.
            What is CDT’s 50-day moving average?
            CDT’s 50-day moving average is 0.18, which suggests CDT is a Sell.
              What is CDT’s 200-day moving average?
              CDT’s 200-day moving average is 2.41, which suggests CDT is a Sell.
                What is CDT’s Williams % R (14)?
                CDT’s Williams % R (14) is -43.75, which suggests CDT is a Buy.
                  What is CDT’s CCI (14)?
                  CDT’s CCI (14) is -35.92, which suggests CDT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis